Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Linbing Qiu

1PUBLICATIONS

10CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Apr 02, 2026

Efficacy and safety of Y90 radioembolization combined with targeted therapy and immunotherapy in patients with unresectable hepatocellular carcinoma: a dual-center, retrospective study.

Xiaolong Wang, Qinggui Jiang, Shiguang Chen

Pageof 1

Frequent Collaborators

1 joint publications

Xiaolong Wang

1 joint publications

Qinggui Jiang

1 joint publications

Shiguang Chen

1 joint publications

Yujie Li

1 joint publications

Cheng Lin

1 joint publications

Wenchang Yu

1 joint publications

Weifu Liu

1 joint publications

Mingzhi Hao

1 joint publications

Yinglang Zeng

1 joint publications

Zhuting Fang

Frequent Collaborators

1 joint publications

Xiaolong Wang

1 joint publications

Qinggui Jiang

1 joint publications

Shiguang Chen

1 joint publications

Yujie Li

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos